MyFinsight
Home
Blog
About
Contact
Investments
$10,980K
Restricted cash and
investments
$10,266K
Inventory
$5,307K
Prepaid expenses and
other current assets
$4,864K
Accounts receivable, net
$4,133K
Cash and cash
equivalents
$3,425K
Total property and
equipment, gross
$42,621K
Total current assets
$38,975K
Property and equipment,
net
$14,040K
Operating lease
right-of-use assets
$3,062K
Finance lease
right-of-use assets
$3,044K
Intangible assets, net
$3,005K
Other long-term
assets
$2,678K
Less accumulated
depreciation and...
$28,581K
Total assets
$64,804K
Total liabilities and
stockholders equity
$64,804K
Total stockholders
equity
$37,463K
Total liabilities
$27,341K
Accumulated deficit
-$727,923K
Additional paid-in capital
$765,373K
Total current
liabilities
$21,228K
Finance lease
liability, net of current...
$3,463K
Operating lease
liability, net of current...
$2,507K
Long-term contract
liabilities
$143K
Accumulated other
comprehensive income
$12K
Common stock, 0.0001
par value...
$1K
Convertible debentures
payable (at fair value)
$10,152K
Accounts payable
$5,062K
Accrued expenses
$3,996K
Contract liabilities
$1,126K
Operating lease liability
$646K
Finance lease liability
$246K
Back
Back
Balance Sheet
Bionano Genomics, Inc. (BNGO)
Bionano Genomics, Inc. (BNGO)
source: myfinsight.com